Sources: Yes, yerba mate contains GLP-1, or more accurately, it stimulates the release of GLP-1 in the body
Assessing the cardiovascular events and clinical outcomes of COVID-19 on patients with primary aldosteronism
Still, safe doesnt mean automatic. The most common issues owners notice are digestivelooser stool, mild nausea, or food refusaloften tied to dose, format, or sudden introduction
Consequently, this prolongs the feeling of fullness (satiety), reduces appetite, and reduces overall calorie intake subsequently leading to negative energy balance and weight loss 18
Clinicians managing patients on testosterone who wish to explore retatrutide should: Consult the relevant clinical trial protocols if the patient is enrolled in a study Seek specialist endocrinology input before initiating any off-label or investigational combination Document clinical rationale clearly , obtain informed consent, and follow GMC Good Practice in Prescribing and Managing Medicines and Devices guidance when considering unlicensed or investigational treatments Until formal guidance is available, clinical decision-making should be guided by individual patient riskbenefit assessment, informed consent, and regular monitoring